Related Experiment Video

Updated: Jul 10, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Focus on nanoparticles for cancer diagnosis and therapeutics

Sang Bok Lee

    Nanomedicine (London, England)
    |November 3, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
    07:59

    A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

    Published on: March 4, 2017

    Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
    17:16

    Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

    Published on: December 9, 2010

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
    07:54

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

    Published on: March 25, 2019

    A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
    07:59

    A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

    Published on: March 4, 2017

    Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
    17:16

    Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

    Published on: December 9, 2010

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Electrochemical Phase Engineering of γ'‑V2O5 Thin Films for Sodium-Ion Storage Electrodes.

    ACS omega·2026

    Extending the Linear Dynamic Range of Single Particle ICP-MS for the Quantification of Microplastics.

    Analytical chemistry·2025

    Chemical and Electrochemical Characterization of Hot-Pressed Li6PS5Cl Solid State Electrolyte: Operating Pressure-Invariant High Ionic Conductivity.

    ChemSusChem·2024

    Development of Korean Menstrual Symptom Scale for University Students.

    Korean journal of women health nursing·2023

    In Situ Raman Mapping of Si Island Electrodes and Stress Modeling as a Function of Lithiation and Size.

    ACS applied materials & interfaces·2023

    Usefulness of additional diffusion MRI acquisition prior to mechanical thrombectomy for acute large vessel occlusion in the early time period at a CT-based stroke center.

    Clinical neurology and neurosurgery·2023

    Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance.

    Nanomedicine (London, England)·2026

    Insights into the use of artificial intelligence in the drug discovery and delivery of nanosystems for the treatment of infectious diseases and neoplasms.

    Nanomedicine (London, England)·2026

    Understanding Mycobacterium tuberculosis host immune responses and identifying synergistic autophagy-inducing compounds as potential nanomedicines for tuberculosis treatment.

    Nanomedicine (London, England)·2026

    Ultrasound-responsive microencapsulated curcumin nanobubbles for treatment of mice rheumatoid arthritis and mechanistic insights based on single-cell Transcriptomics.

    Nanomedicine (London, England)·2026

    The protection of chitosan-coated triptolide-magnesium nanoparticles against intervertebral disc degeneration via MAPK signaling and mitophagy.

    Nanomedicine (London, England)·2026

    Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

    Nanomedicine (London, England)·2026

    Nanostructured lipid carrier system encapsulating bergamot essential oil within an ionic gel-virgin coconut oil matrix: A promising approach for skin health care.

    Journal of advanced pharmaceutical technology & research·2026

    Exogenous copper oxide nanoparticle treatment (seed and foliar) modifies photosynthetic rate and antioxidant enzyme activity in Brassica juncea.

    Frontiers in plant science·2026

    Keratin nanoparticle-loaded hydrogel microneedles for programmed repair of radiation-induced skin injury.

    Journal of materials chemistry. B·2026

    Specific Adsorption of Tumor-Affinity Proteins to Improve Tumor Accumulation for Targeted Imaging and Therapy.

    Small (Weinheim an der Bergstrasse, Germany)·2026

    Development of Stable Nanosubstrates Using ZnO Nanoparticle-Embedded Polymer Composites for Sensitive Detection of MPT64 Antigens.

    ACS applied bio materials·2026

    NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling.

    Experimental & molecular medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us